Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications
Abstract
:1. Introduction
2. Strategies for Engineered Cell Membranes
2.1. Lipid Insertion
2.2. Membrane Hybridization
2.3. Direct Chemical Modification
2.4. Metabolic Glycan Labeling
2.5. Genetic Engineering
3. Nanomaterials for Engineered Cell Membrane Camouflage
3.1. Inorganic Nanoparticles
3.1.1. Magnetic Nanoparticles
3.1.2. Semiconductor Nanoparticles
3.1.3. Rare-Earth Upconversion Nanoparticles
3.1.4. Metal–Organic Framework Nanoparticles
3.1.5. Noble Metal-Based Nanoparticles
3.1.6. Nonmetal-Based Nanoparticles
3.2. Polymeric Nanoparticles
3.2.1. Drug-Carrying Polymeric Nanoparticles
3.2.2. Stimulus-Responsive Polymeric Nanoparticles
3.3. Lipid-Based Nanoparticles
4. Summary and Outlook
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Gavas, S.; Quazi, S.; Karpinski, T.M. Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Res. Lett. 2021, 16, 2021080218. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.Y.; Ren, J.S.; Qu, X.G. Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications. Chem. Rev. 2019, 119, 4357–4412. [Google Scholar] [CrossRef] [PubMed]
- Fang, R.H.; Gao, W.W.; Zhang, L.F. Targeting drugs to tumors using cell membrane-coated nanoparticles. Nat. Rev. Clin. Oncol. 2023, 20, 33–48. [Google Scholar] [CrossRef] [PubMed]
- Mei, H.; Cai, S.S.; Huang, D.N.; Gao, H.L.; Cao, J.; He, B. Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification. Bioact. Mater. 2022, 8, 220–240. [Google Scholar] [CrossRef] [PubMed]
- Huang, L.L.; Wu, H.H.; Xu, D.H.; Gao, J.Q. Recent advances of cell membrane-derived biomimetic nanotechnology in cancer targeted drug delivery system. Acta Pharm. Sin. B 2022, 57, 85–97. [Google Scholar]
- Suk, J.S.; Xu, Q.G.; Kim, N.; Hanes, J.; Ensign, L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Delivery Rev. 2016, 99, 28–51. [Google Scholar] [CrossRef] [PubMed]
- Tian, H.L.; Zhang, T.T.; Qin, S.Y.; Huang, Z.; Zhou, L.; Shi, J.Y.; Nice, E.C.; Xie, N.; Huang, C.H.; Shen, Z.S. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. J. Hematol. Oncol. 2022, 15, 132. [Google Scholar] [CrossRef]
- Zhao, H.L.; Li, N.; Ma, C.X.; Wei, Z.W.; Zeng, Q.Y.; Zhang, K.Y.; Zhao, N.; Tang, B.Z. An AIE probe for long-term plasma membrane imaging and membrane-targeted photodynamic therapy. Chin. Chem. Lett. 2023, 34, 107699. [Google Scholar] [CrossRef]
- Dai, Q.; Wilhelm, S.; Ding, D.; Syed, A.M.; Sindhwani, S.; Zhang, Y.W.; Chen, Y.Y.; MacMillan, P.; Chan, W.C.W. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. ACS Nano 2018, 12, 8423–8435. [Google Scholar] [CrossRef]
- Hu, C.-M.J.; Zhang, L.; Aryal, S.; Cheung, C.; Fang, R.H.; Zhang, L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. USA 2011, 108, 10980–10985. [Google Scholar] [CrossRef]
- Zhen, X.; Cheng, P.H.; Pu, K.Y. Recent Advances in Cell Membrane-Camouflaged Nanoparticles for Cancer Phototherapy. Small 2019, 15, 1804105. [Google Scholar] [CrossRef] [PubMed]
- Yan, Z.; Wang, D.; Gao, Y. Nanomaterials for the treatment of bacterial infection by photothermal/photodynamic synergism. Front. Bioeng. Biotechnol. 2023, 11, 1192960. [Google Scholar] [CrossRef]
- Yan, H.Z.; Shao, D.; Lao, Y.H.; Li, M.Q.; Hu, H.Z.; Leong, K.W. Engineering Cell Membrane-Based Nanotherapeutics to Target Inflammation. Adv. Sci. 2019, 6, 1900605. [Google Scholar] [CrossRef] [PubMed]
- Hao, H.; Chen, Y.; Wu, M. Biomimetic nanomedicine toward personalized disease theranostics. Nano Res. 2020, 14, 2491–2511. [Google Scholar] [CrossRef]
- Lei, W.; Yang, C.; Wu, Y.; Ru, G.Q.; He, X.L.; Tong, X.M.; Wang, S.B. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy. J. Nanobiotechnol. 2022, 20, 45. [Google Scholar] [CrossRef] [PubMed]
- Luk, B.T.; Zhang, L.F. Cell membrane-camouflaged nanoparticles for drug delivery. J. Control. Release 2015, 220, 600–607. [Google Scholar] [CrossRef] [PubMed]
- Zhai, Y.H.; Su, J.H.; Ran, W.; Zhang, P.C.; Yin, Q.; Zhang, Z.W.; Yu, H.J.; Li, Y.P. Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy. Theranostics 2017, 7, 2575–2592. [Google Scholar] [CrossRef]
- Liang, Y.J.; Duan, L.; Lu, J.P.; Xia, J. Engineering exosomes for targeted drug delivery. Theranostics 2021, 11, 3183–3195. [Google Scholar] [CrossRef]
- Xiong, J.Q.; Wu, M.; Chen, J.L.; Liu, Y.F.; Chen, Y.R.; Fan, G.L.; Liu, Y.Y.; Cheng, J.; Wang, Z.H.; Wang, S.X.; et al. Cancer-Erythrocyte Hybrid Membrane-Camouflaged Magnetic Nanoparticles with Enhanced Photothermal-Immunotherapy for Ovarian Cancer. ACS Nano 2021, 15, 19756–19770. [Google Scholar] [CrossRef]
- Chen, R.; Yang, J.; Wu, M.; Zhao, D.; Yuan, Z.; Zeng, L.; Hu, J.; Zhang, X.; Wang, T.; Xu, J.; et al. M2 Macrophage Hybrid Membrane-Camouflaged Targeted Biomimetic Nanosomes to Reprogram Inflammatory Microenvironment for Enhanced Enzyme-Thermo-Immunotherapy. Adv. Mater. 2023, 35, 2304123. [Google Scholar] [CrossRef]
- Dehaini, D.; Wei, X.; Fang, R.H.; Masson, S.; Angsantikul, P.; Luk, B.T.; Zhang, Y.; Ying, M.; Jiang, Y.; Kroll, A.V.; et al. Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization. Adv. Mater. 2017, 29, 1606209. [Google Scholar] [CrossRef] [PubMed]
- Wang, Q.; Cheng, H.; Peng, H.S.; Zhou, H.; Li, P.Y.; Langer, R. Non-genetic engineering of cells for drug delivery and cell-based therapy. Adv. Drug Delivery Rev. 2015, 91, 125–140. [Google Scholar] [CrossRef]
- Ai, X.Z.; Wang, S.Y.; Duan, Y.O.; Zhang, Q.Z.; Chen, M.S.; Gao, W.W.; Zhang, L.F. Emerging Approaches to Functionalizing Cell Membrane-Coated Nanoparticles. Biochemistry 2021, 60, 941–955. [Google Scholar] [CrossRef] [PubMed]
- He, X.; Chang, Z.; Chen, F.; Zhang, W.; Sun, M.; Shi, T.; Liu, J.; Chen, P.; Zhang, K.; Guan, S.; et al. Engineering a biomimetic system for hepatocyte-specific RNAi treatment of non-alcoholic fatty liver disease. Acta Biomater. 2024, 174, 281–296. [Google Scholar] [CrossRef] [PubMed]
- Chai, Z.L.; Ran, D.N.; Lu, L.W.; Zhan, C.Y.; Ruan, H.T.; Hu, X.F.; Xie, C.; Jiang, K.; Li, J.Y.; Zhou, J.F.; et al. Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano 2019, 13, 5591–5601. [Google Scholar] [CrossRef]
- Weise, K.; Huster, D.; Kapoor, S.; Triola, G.; Waldmann, H.; Winter, R. Gibbs energy determinants of lipoprotein insertion into lipid membranes: The case study of Ras proteins. Faraday Discuss. 2013, 161, 549–561. [Google Scholar] [CrossRef]
- Shi, P.; Wang, X.L.; Davis, B.; Coyne, J.; Dong, C.; Reynolds, J.; Wang, Y. In Situ Synthesis of an Aptamer-Based Polyvalent Antibody Mimic on the Cell Surface for Enhanced Interactions between Immune and Cancer Cells. Angew. Chem. Int. Ed. 2020, 59, 11892–11897. [Google Scholar] [CrossRef]
- Sui, S.F.; Wu, H.; Guo, Y.; Chen, K.S. Conformational-Changes of Melittin Upon Insertion into Phospholipid Monolayer and Vesicle. J. Biochem. 1994, 116, 482–487. [Google Scholar] [CrossRef]
- Zhang, Q.; Zhou, J.; Zhou, J.; Fang, R.H.; Gao, W.; Zhang, L. Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis. Nat. Commun. 2021, 12, 4136. [Google Scholar] [CrossRef]
- Fang, R.N.H.; Hu, C.M.J.; Chen, K.N.H.; Luk, B.T.; Carpenter, C.W.; Gao, W.W.; Li, S.L.; Zhang, D.E.; Lu, W.Y.; Zhang, L.F. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale 2013, 5, 8884–8888. [Google Scholar] [CrossRef]
- Kato, K.; Itoh, C.; Yasukouchi, T.; Nagamune, T. Rapid protein anchoring into the membranes of mammalian cells using oleyl chain and poly(ethylene glycol) derivatives. Biotechnol. Prog. 2004, 20, 897–904. [Google Scholar] [CrossRef]
- Song, W.L.; Jia, P.F.; Ren, Y.P.; Xue, J.M.; Zhou, B.Q.; Xu, X.K.; Shan, Y.S.; Deng, J.; Zhou, Q.H. Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics. Bioact. Mater. 2023, 23, 80–100. [Google Scholar] [CrossRef] [PubMed]
- Zou, Y.; Sun, Y.J.; Wang, Y.B.; Zhang, D.Y.; Yang, H.Q.; Wang, X.; Zheng, M.; Shi, B.Y. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nat. Commun. 2023, 14, 4557. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.Y.; Deng, J.; Wang, Y.; Wu, C.Q.; Li, X.; Dai, H.W. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater. 2020, 112, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Chi, S.; Zhang, L.; Cheng, H.; Chang, Y.; Zhao, Y.; Wang, X.; Liu, Z. Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early-Stage Glioma. Angew. Chem. Int. Ed. 2023, 135, e202304419. [Google Scholar] [CrossRef]
- Zhou, Y.; Liang, Q.J.; Wu, X.J.; Duan, S.Z.; Ge, C.L.; Ye, H.; Lu, J.H.; Zhu, R.Y.; Chen, Y.B.; Meng, F.H.; et al. siRNA Delivery against Myocardial Ischemia Reperfusion Injury Mediated by Reversibly Camouflaged Biomimetic Nanocomplexes. Adv. Mater. 2023, 35, 2210691. [Google Scholar] [CrossRef] [PubMed]
- Anguille, S.; Smits, E.L.; Lion, E.; van Tendeloo, V.F.; Berneman, Z.N. Clinical use of dendritic cells for cancer therapy. Lancet Oncol. 2014, 15, E257–E267. [Google Scholar] [CrossRef] [PubMed]
- Xu, C.; Jiang, Y.; Han, Y.; Pu, K.; Zhang, R. A Polymer Multicellular Nanoengager for Synergistic NIR-II Photothermal Immunotherapy. Adv. Mater. 2021, 33, 2008061. [Google Scholar] [CrossRef]
- Liu, W.S.; Wu, L.L.; Chen, C.M.; Zheng, H.; Gao, J.; Lu, Z.M.; Li, M. Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors. Mater. Today Bio 2023, 22, 100751. [Google Scholar] [CrossRef]
- Sletten, E.M.; Bertozzi, C.R. Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality. Angew. Chem. Int. Ed. 2009, 48, 6974–6998. [Google Scholar] [CrossRef]
- Grupi, A.; Ashur, I.; Degani-Katzav, N.; Yudovich, S.; Shapira, Z.; Marzouq, A.; Morgenstein, L.; Mandel, Y.; Weiss, S. Interfacing the Cell with “Biomimetic Membrane Proteins”. Small 2019, 15, 1903006. [Google Scholar] [CrossRef] [PubMed]
- Cai, F.Y.; Ren, Y.F.; Dai, J.J.; Yang, J.M.; Shi, X.A. Effects of Various Cell Surface Engineering Reactions on the Biological Behavior of Mammalian Cells. Macromol. Biosci. 2023, 23, 2200379. [Google Scholar] [CrossRef] [PubMed]
- Xi, Z.; Kong, H.; Chen, Y.; Deng, J.; Xu, W.; Liang, Y.; Zhang, Y. Metal- and Strain-Free Bioorthogonal Cycloaddition of o-Diones with Furan-2(3H)-one as Anionic Cycloaddend. Angew. Chem. Int. Ed. 2022, 61, e202200239. [Google Scholar] [CrossRef] [PubMed]
- Lutterotti, A.; Yousef, S.; Sputtek, A.; Stürner, K.H.; Stellmann, J.P.; Breiden, P.; Reinhardt, S.; Schulze, C.; Bester, M.; Heesen, C.; et al. Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis. Sci. Transl. Med. 2013, 5, 188ra175. [Google Scholar] [CrossRef] [PubMed]
- Jones, R.B.; Mueller, S.; Kumari, S.; Vrbanac, V.; Genel, S.; Tager, A.M.; Allen, T.M.; Walker, B.D.; Irvine, D.J. Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells. Biomaterials 2017, 117, 44–53. [Google Scholar] [CrossRef] [PubMed]
- Wang, W.S.; Gan, Q.; Zhang, Y.Q.; Lu, X.; Wang, H.X.; Zhang, Y.K.; Hu, H.; Chen, L.N.; Shi, L.X.; Wang, S.T.; et al. Polymer-Assisted Metallization of Mammalian Cells. Adv. Mater. 2021, 33, 2102348. [Google Scholar] [CrossRef] [PubMed]
- Sun, Q.; Liu, G.Q.; Wu, H.B.; Xue, H.D.; Zhao, Y.; Wang, Z.L.; Wei, Y.; Wang, Z.M.; Tao, L. Fluorescent Cell-Conjugation by a Multifunctional Polymer: A New Application of the Hantzsch Reaction. ACS Macro Lett. 2017, 6, 550–555. [Google Scholar] [CrossRef]
- Cheng, Q.Z.; Kang, Y.; Yao, B.; Dong, J.R.; Zhu, Y.L.; He, Y.L.; Ji, X.Y. Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy. Adv. Sci. 2023, 10, 2302131. [Google Scholar] [CrossRef]
- Smith, B.A.H.; Bertozzi, C.R. The clinical impact of glycobiology: Targeting selectins, Siglecs and mammalian glycans. Nat. Rev. Drug Discov. 2021, 20, 217–243. [Google Scholar] [CrossRef]
- Nie, W.; Wu, G.; Zhang, J.; Huang, L.-L.; Ding, J.; Jiang, A.; Zhang, Y.; Liu, Y.; Li, J.; Pu, K.; et al. Responsive Exosome Nano-bioconjugates for Synergistic Cancer Therapy. Angew. Chem. Int. Ed. 2020, 59, 2018–2022. [Google Scholar] [CrossRef]
- Han, S.S.; Lee, D.E.; Shim, H.E.; Lee, S.; Jung, T.; Oh, J.H.; Lee, H.A.; Moon, S.H.; Jeon, J.; Yoon, S.; et al. Physiological Effects of Ac4ManNAz and Optimization of Metabolic Labeling for Cell Tracking. Theranostics 2017, 7, 1164–1176. [Google Scholar] [CrossRef] [PubMed]
- Liu, Z.; Sun, M.; Zhang, W.; Ren, J.; Qu, X. Target-Specific Bioorthogonal Reactions for Precise Biomedical Applications. Angew. Chem. Int. Ed. 2023, 62, e202308396. [Google Scholar] [CrossRef] [PubMed]
- Meng, X.Z.; Wang, J.J.; Zhou, J.D.; Tian, Q.M.; Qie, B.; Zhou, G.; Duan, W.; Zhu, Y.M. Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis. Acta Biomater. 2021, 127, 266–275. [Google Scholar] [CrossRef] [PubMed]
- Meng, D.D.; Pan, H.; He, W.; Jiang, X.; Liang, Z.G.; Zhang, X.; Xu, X.Y.; Wang, Z.X.; Zheng, J.L.; Gong, P.; et al. In Situ Activated NK Cell as Bio-Orthogonal Targeted Live-Cell Nanocarrier Augmented Solid Tumor Immunotherapy. Adv. Funct. Mater. 2022, 32, 2202603. [Google Scholar] [CrossRef]
- Au, K.M.; Tisch, R.; Wang, A.Z. Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus. ACS Nano 2021, 15, 19990–20002. [Google Scholar] [CrossRef] [PubMed]
- Zhao, T.; Masuda, T.; Takai, M. pH-Responsive Water-Soluble Polymer Carriers for Cell-Selective Metabolic Sialylation Labeling. Anal. Chem. 2021, 93, 15420–15429. [Google Scholar] [CrossRef] [PubMed]
- Cheng, B.; Tang, Q.; Zhang, C.; Chen, X. Glycan Labeling and Analysis in Cells and In Vivo. Annu. Rev. Anal. Chem. 2021, 14, 363–387. [Google Scholar] [CrossRef]
- Xie, R.; Hong, S.L.; Chen, X. Cell-selective metabolic labeling of biomolecules with bioorthogonal functionalities. Curr. Opin. Chem. Biol. 2013, 17, 747–752. [Google Scholar] [CrossRef]
- Cheng, B.; Xie, R.; Dong, L.; Chen, X. Metabolic Remodeling of Cell-Surface Sialic Acids: Principles, Applications, and Recent Advances. Chembiochem 2016, 17, 11–27. [Google Scholar] [CrossRef]
- Wang, D.; Jiang, S.; Zhang, F.; Ma, S.; Heng, B.C.; Wang, Y.; Zhu, J.; Xu, M.; He, Y.; Wei, Y.; et al. Cell Membrane Vesicles with Enriched CXCR4 Display Enhances Their Targeted Delivery as Drug Carriers to Inflammatory Sites. Adv. Sci. 2021, 8, 2101562. [Google Scholar] [CrossRef]
- Kershaw, M.H.; Westwood, J.A.; Darcy, P.K. Gene-engineered T cells for cancer therapy. Nat. Rev. Cancer 2013, 13, 525–541. [Google Scholar] [CrossRef] [PubMed]
- Hu, Y.C.; Cao, Z.H.; Zheng, L.G.; Shen, J.T.; Zhao, W.; Dai, L. Applications of CRISPR-Cas Technologies in Microbiome Engineering. Chem. J. Chin. Univ. 2023, 44, 20220362. [Google Scholar]
- Xiao, H.; Li, Y.K.; Xing, X.W. Recent Advances in Chemical Control of CRISPR/Cas9 Genome Editing Technology. Chem. J. Chin. Univ. 2023, 44, 20220410. [Google Scholar]
- Yang, Z.L.; Zhang, Z.S. Engineering strategies for enhanced production of protein and bio-products in: A review. Biotechnol. Adv. 2018, 36, 182–195. [Google Scholar] [CrossRef] [PubMed]
- Milone, M.C.; O’Doherty, U. Clinical use of lentiviral vectors. Leukemia 2018, 32, 1529–1541. [Google Scholar] [CrossRef] [PubMed]
- Abbina, S.; Siren, E.M.J.; Moon, H.; Kizhakkedathu, J.N. Surface Engineering for Cell-Based Therapies: Techniques for Manipulating Mammalian Cell Surfaces. ACS Biomater. Sci. Eng. 2017, 4, 3658–3677. [Google Scholar] [CrossRef] [PubMed]
- Zhou, W.Q.; Guo, S.C.; Liu, M.L.; Burow, M.E.; Wang, G.D. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy. Curr. Med. Chem. 2019, 26, 3026–3041. [Google Scholar] [CrossRef] [PubMed]
- Ma, J.N.; Zhang, S.Q.; Liu, J.; Liu, F.Y.; Du, F.; Li, M.; Chen, A.T.; Bao, Y.M.; Suh, H.W.; Avery, J.; et al. Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells. Small 2019, 15, 1902011. [Google Scholar] [CrossRef]
- Liu, J.Q.; Sun, Y.T.; Zeng, X.H.; Liu, Y.; Liu, C.Z.; Zhou, Y.; Liu, Y.G.; Sun, G.H.; Guo, M.X. Engineering and Characterization of an Artificial Drug-Carrying Vesicles Nanoplatform for Enhanced Specifically Targeted Therapy of Glioblastoma. Adv. Mater. 2023, 35, 2303660. [Google Scholar] [CrossRef]
- Feng, M.Y.; Xiong, G.B.; Cao, Z.; Yang, G.; Zheng, S.L.; Song, X.J.; You, L.; Zheng, L.F.; Zhang, T.P.; Zhao, Y.P. PD-1/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett. 2017, 407, 57–65. [Google Scholar] [CrossRef]
- Zhang, X.; Wang, C.; Wang, J.; Hu, Q.; Langworthy, B.; Ye, Y.; Sun, W.; Lin, J.; Wang, T.; Fine, J.; et al. PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy. Adv. Mater. 2018, 30, 1707112. [Google Scholar] [CrossRef] [PubMed]
- Li, B.; Yang, T.; Liu, J.; Yu, X.X.; Li, X.Y.; Qin, F.; Zheng, J.F.; Liang, J.X.; Zeng, Y.Y.; Zhou, Z.H.; et al. Genetically engineered PD-1 displaying nanovesicles for synergistic checkpoint blockades and chemo-metabolic therapy against non-small cell lung cancer. Acta Biomater. 2023, 161, 184–200. [Google Scholar] [CrossRef]
- Krishnan, N.; Peng, F.-X.; Mohapatra, A.; Fang, R.H.; Zhang, L. Genetically engineered cellular nanoparticles for biomedical applications. Biomaterials 2023, 296, 122065. [Google Scholar] [CrossRef] [PubMed]
- Harish, V.; Tewari, D.; Gaur, M.; Yadav, A.B.; Swaroop, S.; Bechelany, M.; Barhoum, A. Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue Engineering, Antimicrobial, and Agro-Food Applications. Nanomaterials 2022, 12, 457. [Google Scholar] [CrossRef] [PubMed]
- Rao, L.; Meng, Q.-F.; Bu, L.-L.; Cai, B.; Huang, Q.; Sun, Z.-J.; Zhang, W.-F.; Li, A.; Guo, S.-S.; Liu, W.; et al. Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging. ACS Appl. Mater. Interfaces 2017, 9, 2159–2168. [Google Scholar] [CrossRef] [PubMed]
- Li, M.; Fang, H.; Liu, Q.; Gai, Y.; Yuan, L.; Wang, S.; Li, H.; Hou, Y.; Gao, M.; Lan, X. Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer. Biomater. Sci. 2020, 8, 1802–1814. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Qiu, Y.; Chen, S.; Huang, J.; Hu, X.; Chen, J.; Wang, S.; Yang, X.; Zhang, Y.; Zhu, Y. Functionalized Tumor Cell Membrane-Camouflaged Photo-Activatable Nanoparticle for Spatiotemporal Antitumor Therapy. Chem. Eng. J. 2023, 474, 145676. [Google Scholar] [CrossRef]
- Deng, J.; Xu, S.; Hu, W.; Xun, X.; Zheng, L.; Su, M. Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer. Biomaterials 2018, 154, 24–33. [Google Scholar] [CrossRef]
- Zou, Y.; Liu, Y.; Yang, Z.; Zhang, D.; Lu, Y.; Zheng, M.; Xue, X.; Geng, J.; Chung, R.; Shi, B. Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine (vol 30, 1803717, 2018). Adv. Mater. 2023, 35, 2300776. [Google Scholar] [CrossRef]
- Wang, Y.C.; Luan, Z.Y.; Zhao, C.Y.; Bai, C.H.; Yang, K.J. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy. Eur. J. Pharm. Sci. 2020, 142, 105136. [Google Scholar] [CrossRef]
- Xu, J.P.; Wang, X.Q.; Yin, H.Y.; Cao, X.; Hu, Q.Y.; Lv, W.; Xu, Q.W.; Gu, Z.; Xin, H.L. Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke. ACS Nano 2019, 13, 8577–8588. [Google Scholar] [CrossRef] [PubMed]
- Park, J.H.; Mohapatra, A.; Zhou, J.; Holay, M.; Krishnan, N.; Gao, W.; Fang, R.H.; Zhang, L. Virus-Mimicking Cell Membrane-Coated Nanoparticles for Cytosolic Delivery of mRNA. Angew. Chem. Int. Ed. 2021, 61, e202113671. [Google Scholar] [CrossRef] [PubMed]
- Guo, Y.; Wang, D.; Song, Q.; Wu, T.; Zhuang, X.; Bao, Y.; Kong, M.; Qj, Y.; Tan, S.; Zhang, Z. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. ACS Nano 2015, 9, 6918–6933. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Z.; Qian, H.; Huang, J.; Sha, H.; Zhang, H.; Yu, L.; Liu, B.; Hua, D.; Qian, X. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int. J. Nanomed. 2018, 13, 4961–4975. [Google Scholar] [CrossRef] [PubMed]
- Hu, Q.Y.; Sun, W.J.; Qian, C.G.; Wang, C.; Bomba, H.; Gu, Z. Anticancer platelet-mimicking nanovehicles. Abstr. Pap. Am. Chem. Soc. 2016, 251, 7043–7050. [Google Scholar] [CrossRef] [PubMed]
- Liu, Z.M.; Zhou, X.F.; Li, Q.; Shen, Y.Q.; Zhou, T.H.; Liu, X.R. Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy. Acta. Pharm. Sin. B 2023, 13, 327–343. [Google Scholar] [CrossRef] [PubMed]
- Shen, S.F.; Dai, H.X.; Fei, Z.Y.; Chai, Y.; Hao, Y.; Fan, Q.; Dong, Z.L.; Zhu, Y.J.; Xu, J.L.; Ma, Q.L.; et al. Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver. ACS Nano 2021, 15, 9111–9125. [Google Scholar] [CrossRef]
- Park, J.H.; Jiang, Y.; Zhou, J.; Gong, H.; Mohapatra, A.; Heo, J.; Gao, W.; Fang, R.H.; Zhang, L. Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs. Sci. Adv. 2021, 7, eabf7820. [Google Scholar] [CrossRef]
- Krishnan, N.; Jiang, Y.; Zhou, J.; Mohapatra, A.; Peng, F.-X.; Duan, Y.; Holay, M.; Chekuri, S.; Guo, Z.; Gao, W.; et al. A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering. Nat. Nanotechnol. 2023, 1748–3387. [Google Scholar] [CrossRef]
- Chen, Z.; Zhao, P.; Luo, Z.; Zheng, M.; Tian, H.; Gong, P.; Gao, G.; Pan, H.; Liu, L.; Ma, A.; et al. Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy. ACS Nano 2016, 10, 10049–10057. [Google Scholar] [CrossRef]
- Han, Y.; Pan, H.; Li, W.; Chen, Z.; Ma, A.; Yin, T.; Liang, R.; Chen, F.; Ma, Y.; Jin, Y.; et al. T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy. Adv. Sci. 2019, 6, 1900251. [Google Scholar] [CrossRef] [PubMed]
- Ai, X.; Wang, D.; Honko, A.; Duan, Y.; Gavrish, I.; Fang, R.H.; Griffiths, A.; Gao, W.; Zhang, L. Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition. J. Am. Chem. Soc. 2021, 143, 17615–17621. [Google Scholar] [CrossRef] [PubMed]
- Yin, T.; Fan, Q.; Hu, F.; Ma, X.; Yin, Y.; Wang, B.; Kuang, L.; Hu, X.; Xu, B.; Wang, Y. Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity. Nano Lett. 2022, 22, 6606–6614. [Google Scholar] [CrossRef]
- Yang, R.; Xu, J.; Xu, L.; Sun, X.; Chen, Q.; Zhao, Y.; Peng, R.; Liu, Z. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination. ACS Nano 2018, 12, 5121–5129. [Google Scholar] [CrossRef] [PubMed]
- Fu, S.; Liang, M.; Wang, Y.; Cui, L.; Gao, C.; Chu, X.; Liu, Q.; Feng, Y.; Gong, W.; Yang, M.; et al. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. ACS Appl. Mater. Interfaces 2019, 11, 1841–1854. [Google Scholar] [CrossRef] [PubMed]
- Zhao, H.J.; Zhao, B.B.; Li, L.; Ding, K.L.; Xiao, H.F.; Zheng, C.X.; Sun, L.L.; Zhang, Z.Z.; Wang, L. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy. Adv. Healthc. Mater. 2020, 9, 1901335. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.Y.; Kang, M.; Choo, Y.W.; Go, S.H.; Kwon, S.P.; Song, S.Y.; Sohn, H.S.; Hong, J.; Kim, B.S. Immunomodulatory Lipocomplex Functionalized with Photosensitizer-Embedded Cancer Cell Membrane Inhibits Tumor Growth and Metastasis. Nano Lett. 2019, 19, 5185–5193. [Google Scholar] [CrossRef] [PubMed]
- Fan, Y.Y.; Cui, Y.X.; Hao, W.Y.; Chen, M.Y.; Liu, Q.Q.; Wang, Y.L.; Yang, M.Y.; Li, Z.P.; Gong, W.; Song, S.Y.; et al. Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma. Bioact. Mater. 2021, 6, 4402–4414. [Google Scholar] [CrossRef]
- Ding, L.; Zhang, X.; Yu, P.; Peng, F.; Sun, Y.; Wu, Y.; Luo, Z.; Li, H.; Zeng, Y.; Wu, M.; et al. Genetically engineered nanovesicles mobilize synergistic antitumor immunity by ADAR1 silence and PDL1 blockade. Mol. Ther. 2023, 31, 2489–2506. [Google Scholar] [CrossRef]
- Lv, W.; Xu, J.; Wang, X.; Li, X.; Xu, Q.; Xin, H. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment. ACS Nano 2018, 12, 5417–5426. [Google Scholar] [CrossRef]
- Chai, Z.; Hu, X.; Wei, X.; Zhan, C.; Lu, L.; Jiang, K.; Su, B.; Ruan, H.; Ran, D.; Fang, R.H.; et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J. Control. Release 2017, 264, 102–111. [Google Scholar] [CrossRef] [PubMed]
- Huang, D.; Wang, Q.; Cao, Y.; Yang, H.; Li, M.; Wu, F.; Zhang, Y.; Chen, G.; Wang, Q. Multiscale NIR-II Imaging-Guided Brain-Targeted Drug Delivery Using Engineered Cell Membrane Nanoformulation for Alzheimer’s Disease Therapy. ACS Nano 2023, 17, 5033–5046. [Google Scholar] [CrossRef]
- Xu, Y.; Du, L.; Han, B.; Wang, Y.; Fei, J.; Xia, K.; Zhai, Y.; Yu, Z. Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma. J. Nanobiotechnol. 2023, 21, 243. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.; Ruan, M.L.; Liu, L.M.; Ji, X.; Ma, Y.D.; Yuan, P.F.; Tang, G.H.; Lin, H.S.; Dai, J.; Xue, W. Self-activated therapeutic cascade of erythrocyte membrane-cloaked iron-mineralized enzymes. Theranostics 2020, 10, 2201–2214. [Google Scholar] [CrossRef] [PubMed]
- Duan, Y.; Wu, M.; Hu, D.; Pan, Y.; Hu, F.; Liu, X.; Thakor, N.; Ng, W.H.; Liu, X.; Sheng, Z.; et al. Biomimetic Nanocomposites Cloaked with Bioorthogonally Labeled Glioblastoma Cell Membrane for Targeted Multimodal Imaging of Brain Tumors. Adv. Funct. Mater. 2020, 30, 2004346. [Google Scholar] [CrossRef]
- Rao, L.; Meng, Q.-F.; Huang, Q.; Wang, Z.; Yu, G.-T.; Li, A.; Ma, W.; Zhang, N.; Guo, S.-S.; Zhao, X.-Z.; et al. Platelet-Leukocyte Hybrid Membrane-Coated Immunomagnetic Beads for Highly Efficient and Highly Specific Isolation of Circulating Tumor Cells. Adv. Funct. Mater. 2018, 28, 1803531. [Google Scholar] [CrossRef]
- Guliz, A.K.; Sanlier, S.H. Erythrocyte membrane vesicles coated biomimetic and targeted doxorubicin nanocarrier: Development, characterization and in vitro studies. J. Mol. Struct. 2020, 1205, 127664. [Google Scholar]
- Zhan, Z.; Zeng, W.Q.; Liu, J.Z.; Zhang, L.; Cao, Y.; Li, P.; Ran, H.T.; Wang, Z.G. Engineered Biomimetic Copper Sulfide Nanozyme Mediates “Don’t Eat Me” Signaling for Photothermal and Chemodynamic Precision Therapies of Breast Cancer. ACS Appl. Mater. Interfaces 2023, 15, 24071–24083. [Google Scholar] [CrossRef]
- Wang, D.; Dong, H.; Li, M.; Cao, Y.; Yang, F.; Zhang, K.; Dai, W.; Wang, C.; Zhang, X. Erythrocyte–Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma. ACS Nano 2018, 12, 5241–5252. [Google Scholar] [CrossRef]
- Tang, Q.; Sun, S.; Wang, P.; Sun, L.; Wang, Y.; Zhang, L.; Xu, M.; Chen, J.; Wu, R.; Zhang, J.; et al. Genetically Engineering Cell Membrane-Coated BTO Nanoparticles for MMP2-Activated Piezocatalysis-Immunotherapy. Adv. Mater. 2023, 35, 2300964. [Google Scholar] [CrossRef]
- Xu, S.; Shi, X.; Ren, E.; Zhang, J.; Gao, X.; Mu, D.; Liu, C.; Liu, G. Genetically Engineered Nanohyaluronidase Vesicles: A Smart Sonotheranostic Platform for Enhancing Cargo Penetration of Solid Tumors. Adv. Funct. Mater. 2022, 32, 2112989. [Google Scholar] [CrossRef]
- Zhu, D.-M.; Xie, W.; Xiao, Y.-S.; Suo, M.; Zan, M.-H.; Liao, Q.-Q.; Hu, X.-J.; Chen, L.-B.; Chen, B.; Wu, W.-T.; et al. Erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy. Nanotechnology 2018, 29, 084002. [Google Scholar] [CrossRef] [PubMed]
- Ye, H.; Wang, K.Y.; Lu, Q.; Zhao, J.; Wang, M.L.; Kan, Q.M.; Zhang, H.T.; Wang, Y.J.; He, Z.G.; Sun, J. Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition. Biomaterials 2020, 242, 119932. [Google Scholar] [CrossRef] [PubMed]
- De Avila, B.E.F.; Angsantikul, P.; Ramírez-Herrera, D.E.; Soto, F.; Teymourian, H.; Dehaini, D.; Chen, Y.J.; Zhang, L.F.; Wang, J. Hybrid biomembrane-functionalized nanorobots for concurrent removal of pathogenic bacteria and toxins. Sci. Robot. 2018, 3, 2470–9476. [Google Scholar]
- Liu, Y.; Wang, X.J.; Ouyang, B.S.; Liu, X.P.; Du, Y.; Cai, X.Z.; Guo, H.S.; Pang, Z.Q.; Yang, W.L.; Shen, S. Erythrocyte-platelet hybrid membranes coating polypyrrol nanoparticles for enhanced delivery and photothermal therapy. J. Mater. Chem. B 2018, 6, 7033–7041. [Google Scholar] [CrossRef] [PubMed]
- Liu, G.N.; Zhao, X.; Zhang, Y.L.; Xu, J.C.; Xu, J.Q.; Li, Y.; Min, H.; Shi, J.; Zhao, Y.; Wei, J.Y.; et al. Engineering Biomimetic Platesomes for pH-Responsive Drug Delivery and Enhanced Antitumor Activity. Adv. Mater. 2019, 31, 1900795. [Google Scholar] [CrossRef] [PubMed]
- Chen, Q.; Huang, G.J.; Wu, W.T.; Wang, J.W.; Hu, J.W.; Mao, J.M.; Chu, P.K.; Bai, H.Z.; Tang, G.P. A Hybrid Eukaryotic-Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination. Adv. Mater. 2020, 32, 1908185. [Google Scholar] [CrossRef]
- Ding, C.P.; Zhang, C.L.; Cheng, S.S.; Xian, Y.Z. Multivalent Aptamer Functionalized AgS Nanodots/Hybrid Cell Membrane-Coated Magnetic Nanobioprobe for the Ultrasensitive Isolation and Detection of Circulating Tumor Cells. Adv. Funct. Mater. 2020, 30, 1909781. [Google Scholar] [CrossRef]
- Zhang, F.; Zhao, L.; Wang, S.; Yang, J.; Lu, G.; Luo, N.; Gao, X.; Ma, G.; Xie, H.-Y.; Wei, W. Construction of a Biomimetic Magnetosome and Its Application as a SiRNA Carrier for High-Performance Anticancer Therapy. Adv. Funct. Mater. 2018, 28, 1703326. [Google Scholar] [CrossRef]
- Zhang, Q.; Wei, W.; Wang, P.; Zuo, L.; Li, F.; Xu, J.; Xi, X.; Gao, X.; Ma, G.; Xie, H.-Y. Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy. ACS Nano 2017, 11, 10724–10732. [Google Scholar] [CrossRef]
- Jiang, X.; Zhang, X.; Guo, C.; Ma, B.; Liu, Z.; Du, Y.; Wang, B.; Li, N.; Huang, X.; Ou, L. Genetically Engineered Cell Membrane-Coated Magnetic Nanoparticles for High-Performance Isolation of Circulating Tumor Cells. Adv. Funct. Mater. 2023, 34, 2304426. [Google Scholar] [CrossRef]
- Zhang, F.; Li, F.; Lu, G.-H.; Nie, W.; Zhang, L.; Lv, Y.; Bao, W.; Gao, X.; Wei, W.; Pu, K.; et al. Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer. ACS Nano 2019, 13, 5662–5673. [Google Scholar] [CrossRef] [PubMed]
- Li, F.; Nie, W.; Zhang, F.; Lu, G.; Lv, C.; Lv, Y.; Bao, W.; Zhang, L.; Wang, S.; Gao, X.; et al. Engineering Magnetosomes for High-Performance Cancer Vaccination. ACS Cent. Sci. 2019, 5, 796–807. [Google Scholar] [CrossRef] [PubMed]
- Rao, L.; Zhao, S.K.; Wen, C.; Tian, R.; Lin, L.; Cai, B.; Sun, Y.; Kang, F.; Yang, Z.; He, L.; et al. Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles. Adv. Mater. 2020, 32, 2004853. [Google Scholar] [CrossRef] [PubMed]
- Bu, Y.; Zhang, X.; Zhu, A.; Li, L.; Xie, X.; Wang, S. Inside-Out-Oriented Cell Membrane Biomimetic Magnetic Nanoparticles for High-Performance Drug Lead Discovery. Anal. Chem. 2021, 93, 7898–7907. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Zhen, X.; Yang, Y.; Feng, Q.; Yuan, W.; Xie, X. Precise assembly of inside-out cell membrane camouflaged nanoparticles via bioorthogonal reactions for improving drug leads capturing. Acta. Pharm. Sin. B 2023, 13, 852–862. [Google Scholar] [CrossRef] [PubMed]
- Bu, Y.; Wu, D.; Zhao, Y.; Wang, G.; Dang, X.; Xie, X.; Wang, S. Genetically Engineered Cell Membrane-Coated Nanoparticles with High-Density Customized Membrane Receptor for High-Performance Drug Lead Discovery. ACS Appl. Mater. Interfaces 2023, 15, 52150–52161. [Google Scholar] [CrossRef] [PubMed]
- Bu, L.-L.; Rao, L.; Yu, G.-T.; Chen, L.; Deng, W.-W.; Liu, J.-F.; Wu, H.; Meng, Q.-F.; Guo, S.-S.; Zhao, X.-Z.; et al. Cancer Stem Cell-Platelet Hybrid Membrane-Coated Magnetic Nanoparticles for Enhanced Photothermal Therapy of Head and Neck Squamous Cell Carcinoma. Adv. Funct. Mater. 2019, 29, 1807733. [Google Scholar] [CrossRef]
- Xie, W.; Deng, W.W.; Zan, M.H.; Rao, L.; Yu, G.T.; Zhu, D.M.; Wu, W.T.; Chen, B.; Ji, L.W.; Chen, L.B.; et al. Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy. ACS Nano 2019, 13, 2849–2857. [Google Scholar] [CrossRef]
- Kim, H.; Shin, K.; Park, O.K.; Choi, D.; Kim, H.D.; Baik, S.; Lee, S.H.; Kwon, S.H.; Yarema, K.J.; Hong, J.; et al. General and Facile Coating of Single Cells via Mild Reduction. J. Am. Chem. Soc. 2018, 140, 1199–1202. [Google Scholar] [CrossRef]
- Dong, X.; Mu, L.-L.; Liu, X.-L.; Zhu, H.; Yang, S.-C.; Lai, X.; Liu, H.-J.; Feng, H.-Y.; Lu, Q.; Zhou, B.-B.S.; et al. Biomimetic, Hypoxia-Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co-Targeting of Therapy-Induced Bone Marrow Niches. Adv. Funct. Mater. 2020, 30, 2000309. [Google Scholar] [CrossRef]
- Wei, X.L.; Beltrán-Gastélum, M.; Karshalev, E.; de Avila, B.E.F.; Zhou, J.R.; Ran, D.N.; Angsantikul, P.; Fang, R.H.; Wang, J.; Zhang, L.F. Biomimetic Micromotor Enables Active Delivery of Antigens for Oral Vaccination. Nano Lett. 2019, 19, 1914–1921. [Google Scholar] [CrossRef] [PubMed]
- Pang, X.; Liu, X.; Cheng, Y.; Zhang, C.; Ren, E.; Liu, C.; Zhang, Y.; Zhu, J.; Chen, X.Y.; Liu, G. Sono-Immunotherapeutic Nanocapturer to Combat Multidrug-Resistant Bacterial Infections. Adv. Mater. 2019, 31, 1902530. [Google Scholar] [CrossRef] [PubMed]
- Cao, Z.; Liu, X.; Zhang, W.; Zhang, K.; Pan, L.; Zhu, M.; Qin, H.; Zou, C.; Wang, W.; Zhang, C.; et al. Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma. ACS Nano 2023, 17, 23746–23760. [Google Scholar] [CrossRef] [PubMed]
- Liu, S.; Wu, J.; Feng, Y.; Guo, X.; Li, T.; Meng, M.; Chen, J.; Chen, D.; Tian, H. CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy. Bioact. Mater. 2023, 22, 211–224. [Google Scholar] [CrossRef] [PubMed]
- Jiang, Q.; Liu, Y.; Guo, R.; Yao, X.; Sung, S.; Pang, Z.; Yang, W. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors. Biomaterials 2019, 192, 292–308. [Google Scholar] [CrossRef] [PubMed]
- Deng, Y.; Ren, M.; He, P.; Liu, F.; Wang, X.; Zhou, C.; Li, Y.; Yang, S. Genetically engineered cell membrane-coated nanoparticles for antibacterial and immunoregulatory dual-function treatment of ligature-induced periodontitis. Front. Bioeng. Biotechnol. 2023, 11, 1113367. [Google Scholar] [CrossRef]
- Su, J.; Sun, H.; Meng, Q.; Yin, Q.; Zhang, P.; Zhang, Z.; Yu, H.; Li, Y. Bioinspired Nanoparticles with NIR-Controlled Drug Release for Synergetic Chemophotothermal Therapy of Metastatic Breast Cancer. Adv. Funct. Mater. 2016, 26, 7495–7506. [Google Scholar] [CrossRef]
- Guo, H.; Zhang, W.; Wang, L.; Shao, Z.; Huang, X. Biomimetic cell membrane-coated glucose/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy. Biomaterials 2022, 290, 121821. [Google Scholar] [CrossRef]
- Cui, Y.; Lv, B.; Li, Z.; Ma, C.; Gui, Z.; Geng, Y.; Liu, G.; Sang, L.; Xu, C.; Min, Q.; et al. Bone-Targeted Biomimetic Nanogels Re-Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis. Small 2023, 2303494. [Google Scholar] [CrossRef]
- Wei, Z.; Xin, F.; Yang, S.; Zhang, C.; Wang, B.; Xue, F.; Guo, Z. Genetically Engineered Cell Membrane Modified Conjugated Polymer Nanoparticles for NIR-II Photothermal Therapy. Adv. Mater. Interfaces 2022, 9, 2200348. [Google Scholar] [CrossRef]
- Wang, S.Y.; Kai, M.X.; Duan, Y.O.; Zhou, Z.D.; Fang, R.H.; Gao, W.W.; Zhang, L.F. Membrane Cholesterol Depletion Enhances Enzymatic Activity of Cell-Membrane-Coated Metal-Organic-Framework Nanoparticles. Angew. Chem. Int. Ed. 2022, 61, e202203115. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.L.; Zou, M.Z.; Liu, T.; Zeng, J.Y.; Li, X.; Yu, W.Y.; Li, C.X.; Ye, J.J.; Song, W.; Feng, J.; et al. Expandable Immunotherapeutic Nanoplatforms Engineered from Cytomembranes of Hybrid Cells Derived from Cancer and Dendritic Cells. Adv. Mater. 2019, 31, 1900499. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.-L.; Zou, M.-Z.; Liu, T.; Zeng, J.-Y.; Li, X.; Yu, W.-Y.; Li, C.-X.; Ye, J.-J.; Song, W.; Feng, J.; et al. Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells. Nat. Commun. 2019, 10, 3199. [Google Scholar] [CrossRef] [PubMed]
- Ge, J.P.; Hu, Y.X.; Biasini, M.; Beyermann, W.P.; Yin, Y.D. Superparamagnetic magnetite colloidal nanocrystal clusters. Angew. Chem. Int. Edit 2007, 46, 4342–4345. [Google Scholar] [CrossRef] [PubMed]
- Rao, L.; Bu, L.L.; Cai, B.; Xu, J.H.; Li, A.; Zhang, W.F.; Sun, Z.J.; Guo, S.S.; Liu, W.; Wang, T.H.; et al. Cancer Cell Membrane-Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging. Adv. Mater. 2016, 28, 3460–3466. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.Y.; Meng, X.F.; Bu, W.B. Upconversion-based photodynamic cancer therapy. Coord. Chem. Rev. 2019, 379, 82–98. [Google Scholar] [CrossRef]
- Zeng, J.-Y.; Zou, M.-Z.; Zhang, M.; Wang, X.-S.; Zeng, X.; Cong, H.; Zhang, X.-Z. π-Extended Benzoporphyrin-Based Metal–Organic Framework for Inhibition of Tumor Metastasis. ACS Nano 2018, 12, 4630–4640. [Google Scholar] [CrossRef]
- Zheng, Q.Y.; Liu, X.M.; Zheng, Y.F.; Yeung, K.W.K.; Cui, Z.D.; Liang, Y.Q.; Li, Z.Y.; Zhu, S.L.; Wang, X.B.; Wu, S.L. The recent progress on metal-organic frameworks for phototherapy. Chem. Soc. Rev. 2021, 50, 5086–5125. [Google Scholar] [CrossRef]
- Kong, F.Y.; Zhang, J.W.; Li, R.F.; Wang, Z.X.; Wang, W.J.; Wang, W. Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications. Molecules 2017, 22, 1445. [Google Scholar] [CrossRef]
- Han, S.T.; Hu, L.; Wang, X.; Zhou, Y.; Zeng, Y.J.; Ruan, S.; Pan, C.; Peng, Z. Black Phosphorus Quantum Dots with Tunable Memory Properties and Multilevel Resistive Switching Characteristics. Adv. Sci. 2017, 4, 1600435. [Google Scholar] [CrossRef] [PubMed]
- Luo, M.; Cheng, W.; Zeng, X.; Mei, L.; Liu, G.; Deng, W. Folic Acid-Functionalized Black Phosphorus Quantum Dots for Targeted Chemo-Photothermal Combination Cancer Therapy. Pharmaceutics 2019, 11, 242. [Google Scholar] [CrossRef] [PubMed]
- Zhu, C.; Xu, F.; Zhang, L.; Li, M.; Chen, J.; Xu, S.; Huang, G.; Chen, W.; Sun, L. Ultrafast Preparation of Black Phosphorus Quantum Dots for Efficient Humidity Sensing. Chem. Eur. J. 2016, 22, 7357–7362. [Google Scholar] [CrossRef]
- Gui, R.J.; Jin, H.; Wang, Z.H.; Li, J.H. Black phosphorus quantum dots: Synthesis, properties, functionalized modification and applications. Chem. Soc. Rev. 2018, 47, 6795–6823. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Li, N.; Pan, W.; Yu, Z.; Yang, L.; Tang, B. Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery. ACS Appl. Mater. Interfaces 2017, 9, 2123–2129. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Pan, H.; Li, J.Y.; Nie, D.; Zhuo, Y.; Lv, Y.S.; Wang, N.; Chen, H.; Guo, S.Y.; Gan, Y.; et al. Cell membrane-coated mesoporous silica nanorods overcome sequential drug delivery barriers against colorectal cancer. Chin. Chem. Lett. 2023, 34, 107828. [Google Scholar] [CrossRef]
- Takada, S.; Yamagata, Y.; Misaki, M.; Taira, K.; Kurokawa, T. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. J. Control. Release 2003, 88, 229–242. [Google Scholar] [CrossRef]
- Saeedi, M.; Eslamifar, M.; Khezri, K.; Dizaj, S.M. Applications of nanotechnology in drug delivery to the central nervous system. Biomed. Pharmacother. 2019, 111, 666–675. [Google Scholar] [CrossRef]
- Overchuk, M.; Weersink, R.A.; Wilson, B.C.; Zheng, G. Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine. ACS Nano 2023, 17, 7979–8003. [Google Scholar] [CrossRef]
- Choi, W.; Park, B.; Choi, S.; Oh, D.; Kim, J.; Kim, C. Recent Advances in Contrast-Enhanced Photoacoustic Imaging: Overcoming the Physical and Practical Challenges. Chem. Rev. 2023, 123, 7379–7419. [Google Scholar] [CrossRef]
- Capozza, M.; Blasi, F.; Valbusa, G.; Oliva, P.; Cabella, C.; Buonsanti, F.; Cordaro, A.; Pizzuto, L.; Maiocchi, A.; Poggi, L. Photoacoustic imaging of integrin-overexpressing tumors using a novel ICG-based contrast agent in mice. Photoacoustics 2018, 11, 36–45. [Google Scholar] [CrossRef] [PubMed]
- Heo, M.; Jeong, J.H.; Ju, S.; Lee, S.J.; Jeong, Y.Y.; Lee, J.D.; Yoo, J.W. Comparison of Clinical Features and Outcomes between SARS-CoV-2 and Non-SARS-CoV-2 Respiratory Viruses Associated Acute Respiratory Distress Syndrome: Retrospective Analysis. J. Clin. Med. 2022, 11, 2246. [Google Scholar] [CrossRef] [PubMed]
- Wei, D.; Sun, Y.; Zhu, H.; Fu, Q. Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics. ACS Nano 2023, 17, 23223–23261. [Google Scholar] [CrossRef] [PubMed]
- Dunn, J.D.; Alvarez, L.A.J.; Zhang, X.Z.; Soldati, T. Reactive oxygen species and mitochondria: A nexus of cellular homeostasis. Redox Biol. 2015, 6, 472–485. [Google Scholar] [CrossRef] [PubMed]
- Yang, H.; Yao, L.H.; Wang, Y.C.; Chen, G.J.; Chen, H. Advancing cell surface modification in mammalian cells with synthetic molecules. Chem. Sci. 2023, 14, 13325–13345. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.J.; Wu, J.Y.; Liu, J.H.; Xu, W.J.; Qiu, X.H.; Huang, S.; Hu, X.B.; Xiang, D.X. Artificial exosomes for translational nanomedicine. J. Nanobiotechnol. 2021, 19, 242. [Google Scholar] [CrossRef] [PubMed]
- Toyofuku, M.; Schild, S.; Kaparakis-Liaskos, M.; Eberl, L. Composition and functions of bacterial membrane vesicles. Nat. Rev. Microbiol. 2023, 21, 415–430. [Google Scholar] [CrossRef]
- White, J.M.; Ward, A.E.; Odongo, L.; Tamm, L.K. Viral Membrane Fusion: A Dance Between Proteins and Lipids. Annu. Rev.Virol. 2023, 10, 139–161. [Google Scholar] [CrossRef]
Engineering Strategies | Principle | Advantages | Limitations |
---|---|---|---|
Lipid insertion | Hydrophobic interactions and fluidity of lipid membranes | Easy to operate; Low time cost | Weak binding force and instability; No specificity |
Membrane hybridization | Fluidity of lipid membranes | Composite multiple membrane functions | Difficulty in determining fusion strategies; Introducing unnecessary molecules; Low accuracy and repeatability |
Direct chemical modification | Forming covalent bond connections, such as acylation reactions | Stable; Persistent | Damage to membrane protein function; No specificity |
Metabolic glycan labeling | Non-natural glycan metabolism | High labeling efficiency; Strong covalent binding in biological orthogonal reactions; Mild conditions; Specificity | Long operation time; Existence of non-specific reactions |
Genetic engineering | Gene editing and gene transduction | The highest specificity; Easy to mass produce; Accurate regulation; Maintaining protein biological activity | Complex process, labor-intensive, and high technical requirements; Limited modifiable cell types; Unstable expression level |
Nanomaterials | Name | Membrane Source | Engineering Methods | Applications | Ref. |
---|---|---|---|---|---|
Upconversion nanoparticles (UCNPs) | FA-RBC-UCNPs | Red blood cell (RBC) | Lipid insertion | Tumor imaging | [75] |
RBC-UCNPs | RBC | Lipid insertion | Tumor imaging | [76] | |
U-ACPT@MM | 4T1 tumor cell | Lipid insertion | Cancer therapy | [77] | |
Bismuth nanoparticles | F-RBC bismuth nanoparticles | RBC | Lipid insertion | Cancer therapy | [78] |
a-dextran loading Dox/Lex | Ang-RBCm@NM-(Dox/Lex) | RBC | Lipid insertion | Cancer therapy | [79] |
Dextran-grafted-poly (histidine) copolymer | DH@ECm | Erythrocyte cancer cell | Membrane hybridization | Cancer therapy | [80] |
Dextran (m-dextran) polymer nanoparticles | tP-NP-rtPA/ZL006e | Platelet (PLT) | Direct chemical modification | Ischemia therapy | [81] |
PLGA | HA-mRNA-NP | B16-HA cell | Genetic engineering | Gene therapy | [82] |
Man-RBC-NPhgp | RBC | Lipid insertion | Cancer vaccines | [83] | |
iE–RBCmGA/PLGA | RBC | Lipid insertion | Cancer therapy | [84] | |
TRAIL-Dox-PM-NV | PLT | Lipid insertion | Cancer therapy | [85] | |
TM-CQ/NP | LX2 cell | Genetic engineering | Stroke therapy | [86] | |
CMNPs | Neural stem cells | Genetic engineering | Cancer therapy | [68] | |
MSC-PD-L1 NPs | Mesenchymal stem cells | Genetic engineering | Inflammation therapy | [87] | |
VLA-DEX-NP | VCAM-1 | Genetic engineering | Cancer therapy | [88] | |
RGD-RBC-NC (DTX) | RBC | Lipid insertion | Lipid insertion | [25] | |
MΦ-NP (L&K) | Macrophage | Cancer therapy | Genetic engineering | [29] | |
mKate2-NPs | HEK293-SC cell | Genetic engineering | Cancer therapy | [89] | |
ICNPs | MCF-7 cell | Metabolic glycan labeling | cancer therapy | [90] | |
n3-tINPs | t cell | Metabolic glycan labeling | Cancer therapy | [91] | |
HP-NS | Host cell | Genetic engineering | Virus therapy | [92] | |
PD-1-MM@PLGA/RAPA | Macrophage | Genetic engineering | Cancer therapy | [93] | |
NP-R@M-M | Cancer cell | Lipid insertion | Cancer vaccines | [94] | |
Solid lipid nanoparticle | T7/NGR-RBCSLNs | RBC | Lipid insertion | Cancer therapy | [95] |
Lipo-Ce6/TPZ@MH | PLT and RBC | Membrane hybridization | Cancer therapy | [96] | |
Lp-KR-CCM-A | 4T1-Fluc cancer cells | Genetic engineering | Cancer therapy | [97] | |
CCM-(PTX) NS | C6 cancer cell | Genetic engineering | Cancer therapy | [98] | |
RBC-NPs | RBC | Lipid insertion | Cancer therapy | [30] | |
siAdar1-LNP@mPD1 | Tumor cell | Genetic engineering | Gene therapy | [99] | |
Dextran polymer core loaded with neuroprotective agent NR2B9C | SHp-RBC-NP | RBC | Lipid insertion | Ischemic stroke therapy | [100] |
Streptavidin–PEG3400–DSPE and biotin–PEG3500–DCDX | D CDX-RBCNPs | RBC | Lipid insertion | Cancer therapy | [101] |
AgAuSe quantum dots (QDs) | RVG-NV-NPs | Neural stem cell | Genetic engineering | Alzheimer’s Disease therapy | [102] |
Black phosphorus quantum dots (BPQDs) | BPQDs-DOX@OPM | PLT and osteosarcoma | Membrane hybridization | Cancer therapy | [103] |
Ultra-small Fe0 nanoparticle (Fe0NP) | GOx-Fe0@EM-A | RBC | Lipid insertion | Cancer therapy | [104] |
cRGD-CM-CPIO | Tumor cell | Metabolic glycan labeling | Tumor imaging | [105] | |
Magnetic beads | HM-IMBs | White blood cell (WBC) and PLT | Membrane hybridization | Circulating tumor cell detection | [106] |
Dispersed starch and PEG diacid-coated magnetic nanoparticles | FVDSPM | RBC | Lipid insertion | Cancer therapy | [107] |
Hollow CuS nanoparticles | CD47@CCM-Lap-CuS NP | Cancer cell | Genetic engineering | Cancer therapy | [108] |
DCuS@ [RBC-B16] NPs | RBC and melanoma cell | Membrane hybridization | Cancer therapy | [109] | |
BTO nanoparticle | M@BTO NPs | HEK293T cell | Genetic engineering | Cancer therapy | [110] |
Purine 18 with DSPE- PEG2000-NH2 | mHAase@nP18 | Baby hamster kidney (BHK-21) cell | Genetic engineering | Cancer therapy | [111] |
Au nanocages (AuNs) | EpCam-RPAuNs | RBC | Lipid insertion | Cancer therapy | [112] |
PNMAuDIs | Neutrophil platelet | Membrane hybridization | Cancer therapy | [113] | |
RBC-PL-robot | RBC platelet | Membrane hybridization | Bacteria therapy | [114] | |
Polypyrrole nanoparticles (PPy NPs) | PPy@ [R–P] NPs | RBC and PLT | Membrane hybridization | Cancer therapy | [115] |
DSPE-PEOz | PEOz-liposome-dox | PLT | Lipid insertion | Cancer therapy | [116] |
PLGA-ICG | PI@EPV | Cytomembrane vesicles (CMVs) and attenuated Salmonella outer membrane vesicles (OMVs) | Membrane hybridization | Cancer vaccines | [117] |
Magnetic nanoparticle-loaded ICG | Fe3O4-ICG@IRM | ID8 ovarian cancer cell RBC | Membrane hybridization | Cancer therapy | [19] |
Fe3O4@SiO2 | HM- Fe3O4@SiO2/Tetra-DNA-Ag2S NDs | WBC and tumor cell | Membrane hybridization | Detection of Circulating tumor cells | [118] |
Magnetic nanocluster (MNC) | RGD-M-MNC:siRNA | Macrophage | Lipid insertion | Gene therapy | [119] |
aAPC | Leukocyte | Metabolic glycan labeling | CTC detection | [120] | |
JE-CM-MNs | Leukemia T lymphocyte | Genetic engineering | CTC detection | [121] | |
Pa-M/Ti-NCs | Leukocyte | Metabolic glycan labeling | Cancer therapy | [122] | |
A/M/C-MNC | Cancer cell | Metabolic glycan labeling | Cancer vaccines | [123] | |
gCM-MN | Macrophages | Genetic engineering | Cancer therapy | [124] | |
IOCMMNPs | Cancer cell | Chemical modification | Cancer therapy | [125] | |
IOCMMNPs | HEK293 cells | Metabolic glycan labeling | Drug discovery | [126] | |
HDFGFR4/CMMNPs | HEK293T cell | Genetic engineering | Drug discovery | [127] | |
Iron oxide magnetic nanoparticle (MN) | CSC-P-MN | PLT and cancer stem cell | Membrane hybridization | Cancer therapy | [128] |
Mesoporous silica nanoparticles | CMSN-GOx | Cancer cell | Genetic engineering | Cancer therapy | [129] |
Ghodamine (green)-containing MSN-coated cells | Single cell | Direct chemical modification | Cell therapy | [130] | |
DAazo@CMSN | NALM-6 cell | Lipid insertion | Leukemia therapy | [131] | |
MSN@CM-GN3 | RAW264.7 cells | Lipid insertion | Gene therapy | [24] | |
Magnesium-based core | Motor-toxoid | RBC | Lipid insertion | Vaccines | [132] |
Superparamagnetic iron oxide nanoparticles (SPIONs) | USM[H]L | M2 macrophage-erythrocyte | Membrane hybridization | Inflammatory therapy | [20] |
Meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) | ANV | HEK 293T cell | Genetic engineering | Bacteria therapy | [133] |
Membrane-penetrating helical polypeptide (P-Ben) and siSav1, a charge-reversal intermediate layer of poly (l-lysine)-cis-aconitic acid (PC) | BSPCA@HM NCs | PLT and macrophage | Membrane hybridization | Gene therapy | [36] |
saALOX15-loaded mesoporous polydopamine (MPDA) | Ang-MMsaNPs | Macrophage | Genetic engineering | Cancer therapy | [134] |
Oleic acid/ D-α-tocopherol polyethylene glycol succinate-lanthanide-doped nanoparticles loading GA and ICG | HMGINPs | Brain metastatic breast cancer cell and glioma cell | Membrane hybridization | Cancer therapy | [35] |
Gboxin loaded poly (4-(4, 4, 5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) benzyl acrylate) (PEG-PHB) | HM-NPs@G | Cancer cell and mitochondrial | Membrane hybridization | Cancer therapy | [33] |
Hyperbranched PEI25k loaded unmethylated cytosine-phosphate-guanine (CpG) | DBE@CCNPs | B16F10 cancer cell | Genetic engineering | Cancer vaccines | [135] |
Melanin | Melanin@RBC-M | RBC/ MCF-7 cell | Membrane hybridization | Cancer therapy | [136] |
Poly (benzobisthiadiazole-alt-thiophene) (pBBTT) | SPNE | Tumor cells and dendritic cells (DCs) | Membrane hybridization | Cancer therapy | [38] |
Fibroin nanoparticles | MSNCs | Macrophage | Genetic engineering | Periodontal therapy | [137] |
Poly (caprolactone)-ester endcap polymer (PCL) | PTX-PN@DiR-RV | RBC | Lipid insertion | Cancer therapy | [138] |
Polydopamine (PDA) | PGT@cRGD-M | Osteosarcoma cell | Lipid insertion | Cancer therapy | [139] |
Nanogel | PNG@mR&C | Bone mesenchymal stem cells | Genetic engineering | Osteoporosis therapy | [140] |
(3E,7E)-3,7-bis (4-(2-decyltetradecyl)-4H-thieno [3,2-b] pyrrole-5,6-dione)-5,7-dihydro pyrrolo [2,3-f] indole-2,6 (1H,3H)-dione (BTPBF) as well as thienyl-diketopyrrolopyrrole (TDPP) | SPN-TF | 293-FT cell | Genetic engineering | Cancer therapy | [141] |
ZIF-8 MOF | CM-MOF-enzyme NP | RBC and macrophage | Membrane hybridization | Enzyme delivery | [142] |
Porphyrin-based Zr-MOF (PCN-224) | PCN@FM | Tumor cells and DCs | Membrane hybridization | Cancer therapy | [143] |
NP@FM | Tumor cells and DCs | Membrane hybridization | Cancer vaccines | [144] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Guan, X.; Xing, S.; Liu, Y. Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications. Nanomaterials 2024, 14, 413. https://doi.org/10.3390/nano14050413
Guan X, Xing S, Liu Y. Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications. Nanomaterials. 2024; 14(5):413. https://doi.org/10.3390/nano14050413
Chicago/Turabian StyleGuan, Xiyuan, Simin Xing, and Yang Liu. 2024. "Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications" Nanomaterials 14, no. 5: 413. https://doi.org/10.3390/nano14050413